Beyond its developmental role, EDA-EDA2R signaling has been intricately linked to conditions such as obesity, insulin resistance, and muscle atrophy [66–70], which collectively contribute to cardiometabolic health decline in aging populations. Here, EDA2R is linked to obesity due to melanocortin 4 receptor deficiency.